Tradestie Institutional Equity Comparison Engine
DTIL vs AKTS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DTIL Overall Edge
DTIL Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Precision BioSciences, Inc. Common Stock (DTIL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DTIL trades at 11.8x Forward P/E with -80.3% operating margin (+37272.4% YoY revenue) versus AKTS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, DTIL sits in CONSOLIDATION (14th %ile IV; Dealer Gamma Walls on Pro) against AKTS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
DTIL
DTIL 11.8x vs AKTS N/M Fwd P/E
Growth & Margin Winner
DTIL
Op Margin -80.3% vs N/A ยท YoY +37272.4% vs N/A
Momentum & Technical Winner
DTIL
1Y +26.2% vs -26.1% ยท 52W Pos 50% vs 13%
Options & Structure Winner
DTIL
CONSOLIDATION (14th %ile IV) vs UNCLASSIFIED (N/A IV)
DTIL
NASDAQ
Precision BioSciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$7.38
-2.38% 1D
Market Cap
$306.9M
1M Return
+27.99%
1Y Return
+26.24%
Forward P/E
11.8x
Unified AI Score
41.0 / 100
SELL
Tech 15.0
Fund 43.0
Flow 70.0
Mom 50.0
AKTS
US Equity
AKTS
Institutional Equity
$16.55
-0.42% 1D
Market Cap
N/A
1M Return
+9.89%
1Y Return
-26.12%
Forward P/E
N/M
Unified AI Score
30.6 / 100
SELL
Tech 20.0
Fund 36.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DTIL +26.24%
AKTS -26.12%
Spread: +114.51 pp (DTIL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
DTIL TTM Op. Margin: -80.3%
AKTS TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DTIL vs AKTS. Trailing 12-month operating profitability (DTIL -80.3% vs AKTS N/A) and valuation multiples (DTIL 11.8x vs AKTS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DTIL | AKTS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $306.9M | N/A | Larger Scale | DTIL |
| Trailing P/E Ratio Valuation | 32.2x | N/M | Lower Multiple | DTIL |
| Forward P/E Ratio Valuation | 11.8x | N/M | Lower Multiple | DTIL |
| Revenue Growth (YoY) Growth | +37272.4% | N/A | Higher Growth | DTIL |
| Operating Margin (TTM) Profitability | -80.3% | N/A | Higher Margin | DTIL |
| Net Profit Margin Profitability | -85.6% | N/A | Higher Margin | DTIL |
| Return on Equity (ROE) Capital Efficiency | -115.3% | N/A | Higher ROE | DTIL |
| 52-Week Range Position Momentum | 50% ($4โ$11) | 13% ($14โ$34) | Stronger Trend | DTIL |
| Beta / 30D Volatility Risk Regime | 0.33ฮฒ ยท 126% Vol | 1.35ฮฒ ยท 67% Vol | Lower Realized Risk | AKTS |
| Unified Institutional Score Composite Signal | 41.0 / 100 (SELL) | 30.6 / 100 (SELL) | Higher Composite | DTIL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DTIL vs AKTS Buy Guide
DTIL
CONSOLIDATION
129d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
14th %ile
IV Regime
Compressed (<25th %ile)
AKTS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DTIL nor AKTS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.